Clinical presentation and risk factors of increased scabies cases in the Western region of Saudi Arabia in 2016-2018

Mohammed Wasil A. Jastaniah, Ziad Faisal K. Zimmo, Mazen Waleed S. Bakallah, Mohannad Saeed S. Hantoush, Mohammed Abdal-Aziz

Abstract


Objectives: To describe the clinical characteristics of scabies in the Makkah province and analyze risk factors associated with the outbreak. 

 

Methods: A cross-sectional study was conducted between June 2016 and June 2018 by collecting the data of patients reported to have infestations at King Abdulaziz Medical City, Makkah, Saudi Arabia. A comparative analysis was conducted of patients reported before and during the outbreak of scabies. 

 

Results: Of the 352 patients identified, the range of cases was 0-24 cases per month before the months of the outbreak (March to April 2018). However, the actual number of cases reported increased 2.8 times the expected maximum in April 2018. Saudi nationals were 2.5 times more affected than non-Saudi nationals during the outbreak period compared to before the outbreak (95%CI: 1.02, 6.05, p=0.045). Symptoms involving upper arms, axillae (53.7% versus 68.7%, p=0.048), and torso (50% versus 66.4%, p=0.033) were significantly under-represented among outbreak patients. The presence of additional comorbidities was reported more frequently in patients diagnosed with scabies before versus during the outbreak months (25.8% versus 8.2%, p=0.014). Permethrin prescriptions increased (75.6% versus 41%), crotamiton prescriptions decreased (13.5% versus 48%), and the hospitalization was lower (3.8% versus 13.5%) during the outbreak. 

 

Conclusion: The clinical presentation and risk factors of scabies change significantly with scabies outbreaks, and consequently so do the lines of treatment in Saudi Arabia. The present study highlights the importance of adopting strategies related to community infection control and prevention.


Keywords


epidemiology; outbreak; prevention; risk factors; Saudi Arabia; scabies; treatment

Full Text:

PDF

References


Gunning K, Pippitt K, Kiraly B, Sayler M. Pediculosis and scabies: treatment update. Am Fam Physician 2012; 86: 535-541.

Strong M, Johnstone PW. Interventions for treating scabies. Cochrane Database Syst Rev 2007: CD000320.

Fathy FM, El-Kasah F, El-Ahwal AM. Clinical and parasitological study on scabies in Sirte, Libya. J Egypt Soc Parasitol 2010; 40: 707-731.

Chung SD, Lin HC, Wang KH. Increased risk of pemphigoid following scabies: a population-based matched-cohort study. J Eur Acad Dermatology Venereol 2014; 28: 558-564.

Hay RJ, Steer AC, Engelman D, Walton S. Scabies in the developing world–its prevalence, complications, and management. Clin Microbiol Infect 2012; 18: 313-323.

Wang CH, Lee SC, Huang SS, Kao YC, See LC, Yang SH. Risk factors for scabies in Taiwan. J Microbiol Immunol Infect 2012; 45: 276-280.

Fuller LC. Epidemiology of scabies. Curr Opin Infect Dis 2013; 26: 123-126.

Thornley S, Marshall R, Jarrett P, Sundborn G, Reynolds E, Schofield G. Scabies is strongly associated with acute rheumatic fever in a cohort study of Auckland children. J Paediatr Child Health 2018; 54: 625-632.

Walton SF, Currie BJ. Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev 2007; 20: 268-279.

Amin T, Ali A, Kaliyadan F. Skin disorders among male primary school children in Al Hassa, Saudi Arabia: prevalence and socio-demographic correlates - a comparison of urban and rural population. Rural Remote Health 2011; 11: 1517.

The Gulf Daily News online desk. 1038 cases of scabies diagnosed in Mecca. [Updated 2018. Cited 2018 December 14th]. Available from: http://www.gdnonline.com/Details/345923/1038-cases-of-scabies-diagnosed-in-Mecca

Mimouni D, Ankol OE, Davidovitch N, Gdalevich M, Zangvil E, Grotto I. Seasonality trends of scabies in a young adult population: A 20-year follow-up. Br J Dermatol 2003; 149: 157-159

Roberts LJ, Huffam SE, Walton SF, Currie BJ. Crusted scabies: Clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect 2005; 50: 375-381.

Romani L, Koroivueta J, Steer AC, Kama M, Kaldor JM, Wand H, et al. Scabies and impetigo prevalence and risk factors in fiji: A national survey. PLoS Negl Trop Dis 2015; 9: e0003452.

Bouvresse S, Chosidow O. Scabies in healthcare settings. Curr Opin Infect Dis 2010; 23: 111-118.

Raza N, Qadir SNR, Agha H. Risk factors for scabies among male soldiers in Pakistan: Case-control study. East Mediterr Heal J 2009; 15: 1105-1110.

Makigami K, Ohtaki N, Ishii N, Yasumura S. Risk factors of scabies in psychiatric and long-term care hospitals: A nationwide mail-in survey in Japan. J Dermatol 2009; 36: 491-498.

Mahé A, Libreville G, Hay RJ. Epidemiology and management of common skin diseases in children in developing countries. Geneva (CH): World Health Organization; 2005.

Hegab DS, Kato AM, Kabbash IA, Dabish GM. Scabies among primary schoolchildren in Egypt: Sociomedical environmental study in Kafr El-Sheikh administrative area. Clin Cosmet Investig Dermatol 2015; 8: 105-011.

Buehlmann M, Beltraminelli H, Strub C, Bircher A, Jordan X, Battegay M, et al. Scabies Outbreak in an intensive care unit with 1,659 exposed individuals-key factors for controlling the outbreak. Infect Control Hosp Epidemiol 2009; 30: 354-360.

Tsutsumi M, Nishiura H, Kobayashi T. Dementia-specific risks of scabies: Retrospective epidemiologic analysis of an unveiled nosocomial outbreak in Japan from 1989-90. BMC Infect Dis 2005; 5: 85.

Feldmeier H, Jackson A, Ariza L, Lins Calheiros CM, de Lima Soares V, Oliveira FA, et al. The epidemiology of scabies in an impoverished community in rural Brazil: Presence and severity of disease are associated with poor living conditions and illiteracy. J Am Acad Dermatol 2009; 60: 436-443.

Makigami K, Ohtaki N, Ishii N, Tamashiro T, Yoshida S, Yasumura S. Risk factors for recurrence of scabies: A retrospective study of scabies patients in a long-term care hospital. J Dermatol 2011; 38: 874-879.

Ministry of Health. MOH News - Statement of clarification on scabies and how to handle reported cases in Makka. 2018 [Updated 2019. Cited 2018 December 14th]. Available from: https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/news-2018-04-03-006.aspx

Dressler C, Rosumeck S, Sunderkötter C, Werner RN, Nast A. Originalarbeit: Therapie der Skabies: Systematische literaturübersicht von randomisierten kontrollierten studien. Dtsch Arztebl Int 2016; 113: 757-762.

Goldust M, Rezaee E, Raghiafar R. Topical ivermectin versus crotamiton cream 10% for the treatment of scabies. Int J Dermatol 2014; 53: 904-908.

Mila-Kierzenkowska C, Woźniak A, Krzyzyńska-Malinowska E, Kałuzna L, Wesołowski R, Poćwiardowski W, et al. Comparative efficacy of topical pertmehrin, crotamiton and sulfur ointment in treatment of scabies. J Arthropod Borne Dis 2017; 11:1-9.


Refbacks

  • There are currently no refbacks.




Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.